Inflammatory cytokines in insulin-treated patients with type 2 diabetes

Nutrition, Metabolism and Cardiovascular Diseases

Volumn 18, Issue 7, 2008, Pages 471-476

  Mavridis, G ^a   Souliou, E ^b   Diza, E ^b   Symeonidis, G ^a   Pastore, F ^a   Vassiliou, A M ^a   Karamitsos, D ^c  

^a Agios Dimitrios General Hospital   (Greece)

^b ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

^c Aristotle University of Thessaloniki   (Greece)

Author keywords

IL 6; Insulin treated patients; sTNFR 60; sTNFR 80; TNF ; Type 2 diabetes

Indexed keywords

ANTIDIABETIC AGENT; CYTOKINE; INSULIN; INTERLEUKIN 6; SULFONYLUREA DERIVATIVE; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR;

AGED; ARTICLE; BIOSYNTHESIS; BLOOD; CASE CONTROL STUDY; FEMALE; HUMAN; IMMUNOLOGY; MALE; METABOLISM; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; RISK FACTOR; SOLUBILITY;

AGED; CASE-CONTROL STUDIES; CYTOKINES; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; INTERLEUKIN-6; MALE; MIDDLE AGED; RECEPTORS, TUMOR NECROSIS FACTOR; RISK FACTORS; SOLUBILITY; SULFONYLUREA COMPOUNDS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 47949111775     PISSN: 09394753     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.numecd.2007.02.013     Document Type: Article

References (28)

1. Festa A., D'Agostino R., Howard G., Mykaanen L., Tracy R., and Haffner S. Chronic subclinical inflammation as part of Insulin Resistance Syndrome. The Insulin Resistance Atherosclerosis Study (IRAS). Circulation 102 (2000) 42-47
2. Thor M., Yu A., and Swedenborg J. Markers of inflammation and hypercoagulability in diabetic and nondiabetic patients with lower extremity ischemia. Thrombosis Res 105 (2002) 379-383
3. Mishima Y., Kuyama A., Tada A., Takahashi K., Ishioka T., and Kibata M. Relationship between serum tumor necrosis factor-α and insulin resistance in obese men with type 2 diabetes mellitus. Diabetes Res Clin Pract 52 (2001) 119-123
4. Heijmans B.T., Westendorp R.G., Droog S., Kluft C., Knook D.L., and Slagboom P.E. Association of the tumour necrosis factor alpha -308G/A polymorphism with the risk of diabetes in an elderly population based cohort. Genes Immun 3 (2002) 225-228
5. Bertin E., Nguyen P., Guenounou M., Durlach V., Potron G., and Leutenegger M. Plasma levels of tumor necrosis factor-alpha (TNF-alpha) are essentially dependent on visceral fat amount in type 2 diabetic patients. Diabetes Metab 26 (2000) 178-182
6. Blüher B., Kratzsch J., and Paschke R. Plasma levels of tumor necrosis factor-α, angiotensin II, growth hormone, and IGF-I are not elevated in insulin-resistant obese individuals with impaired glucose tolerance. Diabetes Care 24 (2001) 328-334
7. Kern P., Ranganathan S., Li C., Wood L., and Ranganathan G. Adipose tissue tumor necrosis factor and interleukin-6 expression in human obesity and insulin resistance. Am J Physiol Endocrinol Metab 280 (2001) E745-E751
8. Pickup J., Chusney G., Thomas S., and Burt D. Plasma interleukin-6, tumour necrosis factor α and blood cytokine production in type 2 diabetes. Life Sci 67 (2000) 291-300
9. Leininen E., Hurt-Camejo E., Wiklund O., Hulten L.M., Hiukka A., and Taskinen M.R. Insulin resistance and adiposity correlate with acute-phase reaction and soluble cell adhesion molecules in type 2 diabetes. Atherosclerosis 166 (2003) 387-394
10. Bullo M., Garciaa-Lorda P., and Salas-Salvado J. Plasma sTNFα receptors and leptin levels in normal-weight and obese women: effect of adiposity and diabetes. Eur J Endocrinol 146 (2002) 325-331
11. Vosarova B., Weyer C., Hanson K., Tataranni P.A., Bogardus C., and Pratley R.E. Circulating interleukin-6 in relation to adiposity, insulin action, and insulin secretion. Obes Res 9 (2001) 414-417
12. Hu F., Meigs J., Li T., Rifai N., and Manson J. Inflammatory markers and risk of developing type 2 diabetes in women. Diabetes 53 (2004) 693-700
13. Duncan B., Schmidt M.I., Pankow J., Ballantyne C., Couper D., Vigo A., et al. Low-grade systemic inflammation and the development of type 2 diabetes. Diabetes 52 (2003) 1799-1805
14. Spranger J., Kroke A., Möhling M., Hoffmann K., Bergmann M., Ristow M., et al. Inflammatory cytokines and the risk to develop type 2 diabetes. Diabetes 52 (2003) 812-817
15. Bastard J.P., Jardel C., Bruckert E., Vidal H., and Hainque B. Variations in plasma soluble tumour necrosis factor receptors after diet-induced weight loss in obesity. Diabetes Obes Metab 2 (2000) 323-325
16. Hube F., Birgel M., Lee Y.M., and Hauner H. Expression pattern of tumor necrosis factor receptors in subcutaneous and omental human adipose tissue: role of obesity and non-insulin-dependent diabetes mellitus. Eur J Clin Invest 29 (1999) 672-678
17. Tsukui S., Kanda T., Nara M., Nishino M., Kondo T., and Kobayashi I. Moderate-intensity regular exercise decreases serum tumor necrosis factor-α and HbA1C levels in healthy women. Int J Obes 24 (2000) 1207
18. Zahorska-Markiewicz B., Janowska J., Olsznecka-Glinianowicz M., and Zurakowski A. Serum concentrations of TNF-α and soluble TNF-α receptors in obesity. Int J Obes 24 (2000) 1392
19. Moller D.E. Potential role of TNF-alpha in the pathogenesis of insulin resistance and type 2 diabetes. Trends Endocrinol Metab 11 (2000) 212-217
20. Bastard J.P., Maachi M., Van Nhieu J.T., Jardel C., Bruckert E., Grimaldi A., et al. Adipose tissue IL-6 content correlates with resistance to insulin activation of glucose uptake both in vivo and in vitro. J Clin Endocrinol Metab 87 (2002) 2084-2089
21. Hotamisligh G.S. The role of TNF-α and TNF receptors in obesity and insulin resistance. J Intern Med 245 (1999) 621-625
22. Senn J.J., Klover P.J., Nowak I.A., and Mooney R.A. Interleukin-6 induces cellular insulin resistance in hepatocytes. Diabetes 51 (2002) 3391-3399
23. King D., Mainous A., Buchanan T., and Pearson W. C-Reactive protein and glycemic control in adults with diabetes. Diabetes Care 26 (2003) 1535-1539
24. Lecheitner M., Herold M., Dzien-Bischinger, Hoppichler F., and Dzien A. Tumor necrosis factor-alpha plasma levels in elderly patients with type 2 diabetes mellitus - observations over 2 years. Diabet Med 19 (2002) 949-953
25. Wu T., Dorn J.P., Donahue R.P., Sempos C.T., and Trevisan M. Associations of serum C-reactive protein with fasting insulin, glucose, and glycosylatedd hemoglobin. Am J Epidemiol 155 (2002) 65-71
26. Salmenniemi U., Vauhkonen I., Kainulainen S., Punnonen K., Vanninen E., and Laakso M. Multiple abnormalities in glucose and energy metabolism and coordinated changes in levels of adiponectin, cytokines, and adhesion molecules in subjects with metabolic syndrome. Circulation 21 (2004) 3842-3848
27. Ryan A.S., and Nicklas B.J. Reductions in plasma cytokine levels with weight loss improve insulin sensitivity in overweight and obese postmenopausal woman. Diabetes Care 27 (2004) 1699-1705
28. Rodrguez-Moran M., and Guerrero-Romero F. Increased levels of C-reactive protein in noncontrolled type II diabetic subjects. J Diab Comp 13 (1999) 211-215